Donville Kent On The Little Book That Builds Wealth and The Outsiders

Donville Kent On The Little Book That Builds Wealth and The Outsiders

J.P. Donville of Donville Kent enjoys reading The Little Book That Builds Wealth by Pat Dorsey and The Outsiders by William N. Thorndike, Jr,

Donville Kent: Net Worth

2014 was another solid year for Canadian equity investors and a strong year for the Capital Ideas Fund. In 2014, the S&P/TSX Total Return Index rose 10.6%1 while the Capital Ideas Fund was up 22.7%2. In 2014, the key portfolio decisions we made were to be overweight knowledge-based industries (pharmaceuticals, software, IT services) and relatively underweight natural resource stocks. As most investors are aware, oil, along with most other commodities, nosedived in the second half of 2014.

As we enter 2015, we have a few concerns. Both the US Dollar and oil have made massive moves in terms of price, and I expect that the effects of these moves have yet to be fully felt. In the coming months, the appreciation (US$) and depreciation (oil) of these two items will have a significant impact on earnings forecasts and employment in Canada and abroad. The exact winners and losers will become more obvious as the year unfolds. Until then, we are playing things a bit cautiously.

Qualivian Investment Partners July 2022 Performance Update

stocks performance 1651757664Qualivian Investment Partners performance update for the month ended July 31, 2022. Q2 2022 hedge fund letters, conferences and more Dear Friends of the Fund, Please find our July 2022 performance report below for your review. Qualivian reached its four year track record in December 2021.  We are actively weighing investment proposals. Starting in November Read More

As far as the positioning of the Capital Ideas Fund goes, we look relatively similar at the start of 2015 to the way we were in 2014, with the exception that we are relatively light on financial services companies. Natural resource and financial services companies make up roughly 70% of the TSX’s capitalisation, but at the time of this writing they make up less than 15% of the Capital Ideas Fund. So what then do we own? We currently have 23% of the fund in pharmaceutical companies and